MedTrace Logo

Active Aging With Technological Devices

NCT05891912 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-06-07

No results posted yet for this study

Summary

Clinical trial with users of health care centres and nursing homes in Extremadura (Spain). Inclusion criteria are: women and men over 55 years of age with a Minimental State Examination (MMSE) equal or higher than 21 (no cognitive impairment or mild to moderate cognitive impairment) who are able to walk independently. Exclusion criteria are: patients with severe cognitive impairment or language impairment that prevents the use of verbal communication, non-autonomous gait and severe limitation of mobility at the level of the upper limb.

Treatment schedule: 30 min sessions, twice a week during 12 weeks

* 1 session per week: 15min small TABLET and 15min LIGHTS game.
* 1 session per week: 15min TABLE TABLET and 15min game of grape harvesting.

The intervention will be carried out by occupational therapists or physiotherapists.

The intervention period and evaluations will be performed as follows:

* Training of Occupational therapists/physiotherapists: 1 week prior to the start of the intervention for.
* Week 0- Initial measurements
* Week 1-12: device interventions
* Week 13: Final measurements
* Week 17: First follow-up measurement
* Week 21: Second follow-up measurement

Conditions

  • Older Adults Institutionalized in Residential Homes

Interventions

OTHER

Technological devices intervention (use of tablet and big screen with games oriented to training physical and cognitive function)

The treatment will be performed in 30 min sessions, twice a week during 12 weeks. the weekly sessions will include the following games: * 1 session per week: 15min small TABLET and 15min LIGHTS game. * 1 session per week: 15min TABLE TABLET and 15min game of VINTAGE.

Sponsors & Collaborators

  • University of Extremadura

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-09-01
Completion
2023-11-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05891912 on ClinicalTrials.gov